Retrospective and prospective analyses of cohorts with pathogenic ANKRD11 variants will be crucial to confirm the occurrence of movement disorders in this condition, which will be important for guiding clinical management and identifying potential therapeutic targets based on the gene’s known function. Here, ANKRD11 is linked to movement disorder.